Overview

Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.

Status:
NOT_YET_RECRUITING

Trial end date:
2027-04-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of DEP114 in the treatment of Moderate to Severe Persistent Allergic Rhinitis in children aged between 6 and 11 years.

Phase:

PHASE3

Details

Lead Sponsor:

EMS

Treatments:

desloratadine